Form 4: Centene Director James Dallas Reports Acquisition of Restricted Stock Units

Director James Dallas reported acquiring 3,579 restricted stock units of Centene Corp, vesting in 2026, and indirectly owns 1,693 shares through a family trust.

Summary

• James Dallas, a director of Centene Corp, filed a Form 4 detailing changes in beneficial ownership.
• On May 13, 2025, Mr. Dallas acquired 3,579 shares of restricted stock units, which will vest on the earlier of May 13, 2026, or the date of the next annual meeting of stockholders.
• The acquisition price for these restricted stock units was $0.
• Following the transaction, Mr. Dallas directly owns 43,882.185 shares of Centene common stock.
• Mr. Dallas also indirectly owns 1,693 shares through a revocable family trust where he serves as a co-trustee.
• Mr. Dallas also owns options to purchase 10,000 shares of common stock at an exercise price of $62.81, which were granted on February 3, 2023, and expire on February 3, 2030.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a company director. The acquisition of restricted stock units is generally a positive sign, indicating alignment with shareholder interests, but it's not a major event.

Positives

• The acquisition of restricted stock units aligns Mr. Dallas' interests with those of the shareholders, as the vesting is tied to his continued service or the company's performance.

Future Outlook

The vesting of the restricted stock units is contingent upon continued service or the company's performance until May 13, 2026, or the next annual meeting of stockholders.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in the company's stock. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Equity compensation is a common practice among publicly traded companies to align the interests of executives and directors with those of shareholders.
• The vesting schedule of the restricted stock units is typical, often tied to continued service or performance milestones.
• Comparing the size of the equity grants to those of directors at similar healthcare companies (e.g., UnitedHealth Group, Anthem) would provide a benchmark for assessing the magnitude of this award.

Stakeholder Impact

• The acquisition of restricted stock units by a director can be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates

Keywords

Centene, Director, Form 4, Beneficial Ownership, Restricted Stock Units, CNC, James Dallas